Yüklüyor......
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
A major barrier for cancer immunotherapy is the presence of suppressive cell populations in cancer patients, such as myeloid-derived suppressor cells (MDSC) and tumor-associated macrophages (TAM), which contribute to the immunosuppressive microenvironment that promotes tumor growth and metastasis. T...
Kaydedildi:
| Yayımlandı: | Cancer Immunol Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323929/ https://ncbi.nlm.nih.gov/pubmed/25370534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0036 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|